Newton (formerly Neurolens) announced that it has selected ABB Labs as a strategic lab partner. This collaboration dramatically expands access to Newton's lens portfolio, including Neurolens and Sequel, by leveraging ABB Labs' United States-based footprint and established relationships with independent optometry, according to Newton.

According to the company, Neurolens has patented Contoured Prism technology for relief from headaches, neck pain and motion sickness; and Sequel is an everyday lens with proprietary Convergence Boost technology for visual comfort and clarity both on screen and off.

Newton's Neurolens and Sequel lenses are now available to order through ABB Labs. Additionally, a limited-time partnership incentive is available to new Newton customers working with ABB Optical Group.